Sun Pharma Advanced Research Company Limited

Web: sparc.life NSE: SPARC BSE: 532872 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

237 4(2%)

Near 52W High of 249

Volume

5L as on 14, Jul

Open

161

High

203

Low

200

Close

233

VWAP

162

52 Week High

249

52 Week Low

108

Viand Research Rating
Quality Score

00/00

Growth Score

00/00

Valuation Score

00/00

Momentum Score

00/00

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

7,696

No. of Shares

32.4

P/E

-16.14

P/B

-83.39

Face Value

1

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

516.23

ROCE

-

Profit Growth

-

Listing Date

18-Jul-07

Promoter Holding

65.67%

FII Holding

2.04%

DII Holding

0.88%

Price Chart
Price Performance
1 Week3%
1 Month3%
3 Months11%
6 Months10%
1 Year32%
YTD20%
Moving Average
5 Day SMA158
10 Day SMA159
20 Day SMA158
30 Day SMA161
50 Day SMA161
61 Day SMA159
80 Day SMA156
200 Day SMA174
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 3171162167171
Resistance 2167161164167
Resistance 1163160162163
Pivot Point159159159159
Support 1155159156155
Support 2152158155151
Support 3148157152147
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqDiv Yld %NP Qtr Rs.Cr.
1SUNPHARMA4,42,18718432%14%2%9%39000
2DIVISLAB1,80,28067912%6%4%1%65000
3TORNTPHARM1,53,28145290%8%18%40%64000
4APOLLOHOSP1,19,04782803%7%12%17%58000
5CIPLA1,14,86914221%10%7%4%22000
6DRREDDY1,11,01513300%1%7%7%20000
7ZYDUSLIFE1,09,37810876%16%15%17%20000
8LUPIN1,04,01722751%2%9%15%23000
9MANKIND1,00,48224343%7%7%2%49000
10MAXHEALTH96,8679957%1%15%14%0000
Load More
Shareholding Pattern (%)
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 65.67%(0.01) 65.67%(0.01) 65.67%(0.01) 65.67%(0.01) 65.68%(0.01) 65.68%(0.01) 65.68%(0.01) 65.68%(0.01) 65.68%(0.01) 65.68%(0.01) 65.68%(0.01) 65.68%(-2.61) 65.68%(-0.91) 68.23%(0.01) 69.09%(0.01) 69.09%(1.01) 69.09%(0.01) 68.10%(0.01) 68.10%
FIIs(0.01) 2.04%(0.31) 2.04%(0.31) 1.76%(0.01) 1.47%(-0.81) 1.45%(0.11) 2.23%(-0.51) 2.15%(-0.61) 2.64%(-0.11) 3.24%(-0.41) 3.30%(0.01) 3.67%(0.01) 3.64%(0.21) 3.64%(1.11) 3.48%(0.01) 2.38%(0.01) 2.40%(-0.11) 2.38%(0.01) 2.51%(0.01) 2.54%
DIIs(0.11) 0.88%(-0.31) 0.78%(0.11) 1.05%(-0.21) 0.97%(0.51) 1.13%(0.41) 0.64%(0.01) 0.21%(-0.51) 0.17%(0.01) 0.67%(0.01) 0.67%(0.01) 0.65%(0.01) 0.63%(-0.11) 0.63%(0.01) 0.76%(0.01) 0.76%(0.01) 0.76%(0.21) 0.76%(0.01) 0.55%(0.01) 0.56%
Public31.41%31.51%31.52%31.88%31.76%31.47%31.96%31.51%30.41%30.36%29.99%30.06%30.04%27.53%27.77%27.75%27.77%28.84%28.81%
No. of Shareholders140,625144,810136,997140,724142,864131,034128,205125,184102,743103,990101,433100,80798,77796,33793,71894,49492,73695,03994,834
Quarterly Results
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Sales18538810271513171714212448
Expenses806574628089116110122116113126137
Operating Profit1773-57-66-52-53-74-103-93-106-103-91-102-90
OPM %96-670-836-540-196-494-800-555-639-740-432-427-188
Other Income2-120900024681011
Interest12986531110000
Depreciation2333333333333
Profit before tax1761-80-76-52-61-79-107-96-105-100-86-95-82
Tax %0000-100000000
Net Profit 1761-80-76-52-60-80-107-96-106-100-86-95-82
EPS in Rs54.27-2.48-2.34-1.6-1.84-2.45-3.31-2.96-3.26-3.07-2.66-2.94-2.53
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023
Sales18797276239
Expenses280395478453
Operating Profit1599-323-402-214
OPM %85-450-532-90
Other Income-122911
Interest34928
Depreciation10121312
Profit before tax1553-343-387-223
Tax %0000
Net Profit 1553-343-387-223
EPS in Rs47.86-10.55-11.93-6.86
Dividend Payout %0000
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023
Cash from Operating Activity-239-360-429-69
Cash from Investing Activity-24158392-548
Cash from Financing Activity26119942617
Net Cash Flow-1-35-1
Balance Sheet
Mar 2026Sep 2025Mar 2025Mar 2024Mar 2023
Equity Capital3232323232
Reserves1306-377-24993480
Borrowings5594172696116
Other Liabilities273250284328302
Total Liabilities2171322336515830
Fixed Assets15716299108106
CWIP01544427
Investments0002291
Other Assets2014160183362406
Total Assets2171322336515830
Delivery
#Date
108
130%
249
Value (Cr)Q/T
160
Del
39
Del
56
127-May221
243
1492561
226-May236
901
14612111
325-May233
1380
140682
422-May210
659
1321387
521-May180
80
1052520
620-May184
162
1002032
719-May180
771
128865
818-May162
22
69358
915-May164
20
73408
1014-May170
25
73338
1113-May169
52
773116
1212-May166
45
733214
1311-May168
38
893312
148-May173
154
1012844
157-May167
119
1012834
166-May157
336
1491757
175-May140
44
1576428
184-May140
35
1516322
1930-Apr143
138
1554257
2029-Apr149
21
2517215
2128-Apr147
19
2057214
2227-Apr147
52
1433921
2324-Apr139
8
92363
2423-Apr143
12
105354
2522-Apr144
6
92282
2621-Apr144
8
109373
2720-Apr144
8
95383
2817-Apr148
16
115467
2916-Apr152
21
126357
3015-Apr151
51
1252513
3113-Apr142
13
117274
3210-Apr148
30
119288
339-Apr146
148
1361421
348-Apr136
33
108279
357-Apr126
21
88194
366-Apr123
11
77313
372-Apr124
11
92253
381-Apr120
11
107243
3930-Mar115
33
1304615
4027-Mar121
36
118238
4125-Mar131
177
157815
4224-Mar112
9
103555
4323-Mar109
7
95524
4420-Mar115
5
98422
Daily Market Cap
DateTotal Market CapChangeChg %
26-May7,696c44c0.57
25-May7,652c1,632c27.12
22-May6,020c137c2.33
21-May5,883c56c0.94
20-May5,938c97c1.67
19-May5,841c621c11.89
18-May5,220c103c1.93
15-May5,323c240c4.32
14-May5,563c175c3.24
12-May5,389c92c1.68
11-May5,481c57c1.05
07-May5,424c381c7.56
06-May5,043c495c10.88
05-May4,548c9c0.21
04-May4,539c305c6.30
30-Apr4,844c4c0.09
29-Apr4,839c69c1.45
28-Apr4,770c251c5.55
24-Apr4,519c186c3.95
23-Apr4,705c50c1.08
22-Apr4,655c34c0.73
21-Apr4,689c88c1.83
17-Apr4,777c193c3.89
15-Apr4,970c00
Stock Checklist
Price is above from 52 week high low average: 83%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: NO
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: NO
Mutual Fund Holdings
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
0